<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00561600</url>
  </required_header>
  <id_info>
    <org_study_id>04062</org_study_id>
    <nct_id>NCT00561600</nct_id>
  </id_info>
  <brief_title>Multi-Center Comparative Trial of the ASR™-XL Acetabular Cup System vs. the Pinnacle™ Metal- on- Metal Total Hip System</brief_title>
  <acronym>ASR</acronym>
  <official_title>A Randomized, Prospective, Comparative, Multi-Center Clinical Evaluation of the DePuy ASR™-XL Acetabular Cup System vs. the Pinnacle™ Metal- on- Metal Total Hip System Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>DePuy Orthopaedics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>DePuy Orthopaedics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this investigation is to evaluate the clinical and radiographic
      outcomes of the ASR™-XL Acetabular Cup System compared to the Pinnacle™ Acetabular Cup with a
      28mm or 36mm ULTAMET™ metal insert.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this clinical investigation is to gather sufficient clinical and radiographic
      data to permit valid scientific comparisons between treatment and control group outcomes. The
      treatment group/device for this study is the ASR™-XL Acetabular Cup System, and the control
      group/device is the Pinnacle™ Cup System w/ the 28mm or 36mm ULTAMET™ metal liner. The study
      objective will be achieved by way of treatment group selection, treatment administration, and
      management of participating study Subjects.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2006</start_date>
  <completion_date type="Actual">January 1, 2012</completion_date>
  <primary_completion_date type="Actual">January 1, 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite Success Based Upon Harris Hip Score, Radiographic and Survivorship Outcomes</measure>
    <time_frame>24-month interval.</time_frame>
    <description>&quot;Composite success: 1) Revision free (life of study) 2) No evidence of radiographic failure (life of study) 3) Harris Hip score =&gt; 80 at 24 months&quot;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>T-Test of Harris Hip Total Score Means at 24 Months</measure>
    <time_frame>24 months</time_frame>
    <description>T-Test of Harris Hip total score means at 24 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Harris Hip Pain Sub Score at 24 Months</measure>
    <time_frame>24 months</time_frame>
    <description>Mean Harris Hip Pain sub score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Harris Hip Function Score at 24 Months</measure>
    <time_frame>24 months</time_frame>
    <description>Mean Harris Hip Function sub score at 24 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of Metal Ion Release - Serum Cobalt</measure>
    <time_frame>Pre-operative</time_frame>
    <description>Serum Cobalt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of Metal Ion Release - Serum Chromium</measure>
    <time_frame>pre-operative</time_frame>
    <description>Serum Chromium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of Metal Ion Release - Erythrocyte Cobalt</measure>
    <time_frame>pre-operative</time_frame>
    <description>Erythrocyte cobalt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of Metal Ion Release - Erythrocyte Chromium</measure>
    <time_frame>Pre-operative</time_frame>
    <description>Erythrocyte Chromium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of Metal Ion Release - Serum Cobalt</measure>
    <time_frame>4 months post-operative</time_frame>
    <description>Serum Cobalt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of Metal Ion Release - Serum Chromium</measure>
    <time_frame>4 months post operative</time_frame>
    <description>Serum Chromium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of Metal Ion Release - Erythrocyte Cobalt</measure>
    <time_frame>4 months post-operative</time_frame>
    <description>Erythrocyte Cobalt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of Metal Ion Release - Erythrocyte Chromium</measure>
    <time_frame>4 months post-operative</time_frame>
    <description>Erythrocyte Chromium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of Metal Ion Release - Serum Cobalt</measure>
    <time_frame>12 months post-operative</time_frame>
    <description>Serum Cobalt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of Metal Ion Release - Serum Chromium</measure>
    <time_frame>12 Months</time_frame>
    <description>Serum Chromium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of Metal Ion Release - Erythrocyte Cobalt</measure>
    <time_frame>12 Months</time_frame>
    <description>Erythrocyte Cobalt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of Metal Ion Release - Erythrocyte Chromium</measure>
    <time_frame>12 months</time_frame>
    <description>Erythrocyte Chromium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of Metal Ion Release - Serum Cobalt</measure>
    <time_frame>24 months</time_frame>
    <description>Serum Cobalt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of Metal Ion Release - Serum Chromium</measure>
    <time_frame>24 months</time_frame>
    <description>Serum Chromium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of Metal Ion Release - Erythrocyte Cobalt</measure>
    <time_frame>24 months</time_frame>
    <description>Erythrocyte Cobalt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of Metal Ion Release - Erythrocyte Chromium</measure>
    <time_frame>24 months</time_frame>
    <description>Erythrocyte Chromium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of Metal Ion Release - Serum Cobalt</measure>
    <time_frame>36 months</time_frame>
    <description>Serum Cobalt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of Metal Ion Release - Serum Chromium</measure>
    <time_frame>36 months</time_frame>
    <description>Serum Chromium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of Metal Ion Release - Erythrocyte Cobalt</measure>
    <time_frame>36 months</time_frame>
    <description>Erythrocyte cobalt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of Metal Ion Release - Erythrocyte Chromium</measure>
    <time_frame>36 months</time_frame>
    <description>Erythrocyte chromium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of Metal Ion Release - Serum Cobalt</measure>
    <time_frame>48 months</time_frame>
    <description>Serum Cobalt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of Metal Ion Release - Serum Chromium</measure>
    <time_frame>48 months</time_frame>
    <description>Serum Chromium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of Metal Ion Release - Erythrocyte Cobalt</measure>
    <time_frame>48 months</time_frame>
    <description>Erythrocyte Cobalt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of Metal Ion Release - Erythrocyte Chromium</measure>
    <time_frame>48 months</time_frame>
    <description>Erythrocyte chromium</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">265</enrollment>
  <condition>Non-inflammatory Degenerative Joint Disease</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ASR™-XL Modular Acetabular Cup System stem</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pinnacle™ acetabular shell, with a 28mm or 36mm ULTAMET® metal liner, and a 28mm or 36mm Articul/eze M head.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ASR™-XL Modular Acetabular Cup System</intervention_name>
    <description>The ASR™-XL Modular Acetabular Cup System treatment device is comprised of a metal acetabular cup, a unipolar femoral head and a taper sleeve adapter.</description>
    <arm_group_label>A</arm_group_label>
    <other_name>Acetabular cup replacement</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pinnacle™ acetabular shell</intervention_name>
    <description>The Pinnacle™ shells are cementless, titanium alloy cups with Porocoat® porous coating and HA DuoFix™ coating. There are various different liners available for use with the Pinnacle™ Acetabular Cup System. For the purpose of this investigation, the CoCrMo ULTAMET® 28mm or 36 mm metal liners will be used.</description>
    <arm_group_label>B</arm_group_label>
    <other_name>Acetabular cup replacement</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is able to or capable of providing consent to participate in the clinical
             investigation.

          -  Subject is between the ages of 20-75 years, inclusive.

          -  Subject requires a cementless, primary total hip arthroplasty for non-inflammatory
             degenerative joint disease (NIDJD).

          -  Subject has sufficient bone stock for the hip replacement device.

          -  Subject is a suitable candidate for the devices specified in the clinical
             investigation plan and is willing to be randomized to either cup system device.

        Exclusion Criteria:

          -  Subject, in the opinion of the Investigator, has an existing condition that would
             compromise his/her participation and follow-up in this investigation.

          -  Subject with a known allergy to metal (e.g. jewelry).

          -  Subject has inflammatory arthritis (e.g. rheumatoid arthritis).

          -  Subject has active or recent joint sepsis.

          -  Subject with marked atrophy or deformity in the upper femur.

          -  Subject with a neuromuscular disease where the loss of musculature would affect
             functional outcome.

          -  Subject, in the opinion of the Clinical Investigator, has a history of chronic renal
             insufficiency (e.g. dialysis).

          -  Subject is receiving systemic steroid therapy, excluding inhalers or intra-capsular
             injections, within 3 months prior to surgery.

          -  Subject with known, active metastatic or neoplastic disease.

          -  Subject is known to be pregnant, a prisoner, mentally incompetent, and or alcohol or
             drug abuser.

          -  Subject is currently involved in any personal injury litigation, medical legal or
             worker's compensation claims.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dave Whalen, BS, DC</last_name>
    <role>Study Director</role>
    <affiliation>DePuy Orthopaedics</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Desert Orthopaedics</name>
      <address>
        <city>Rancho Mirage</city>
        <state>California</state>
        <zip>92270</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Resurgens Orthopaedics</name>
      <address>
        <city>Cumming</city>
        <state>Georgia</state>
        <zip>30041</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Illinois Bone and Joint Institute</name>
      <address>
        <city>Morton Grove</city>
        <state>Illinois</state>
        <zip>60053</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spectrum Health Hospital Research</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503-2550</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dartmouth-Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756-0001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eastern Oklahoma Orthopedic Center</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orthopaedic Specialists of Austin</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Valley Orthopaedic Associates</name>
      <address>
        <city>Renton</city>
        <state>Washington</state>
        <zip>98055-5791</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 20, 2007</study_first_submitted>
  <study_first_submitted_qc>November 20, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 21, 2007</study_first_posted>
  <results_first_submitted>February 5, 2014</results_first_submitted>
  <results_first_submitted_qc>April 7, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 7, 2014</results_first_posted>
  <last_update_submitted>July 10, 2017</last_update_submitted>
  <last_update_submitted_qc>July 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hip arthroplasty</keyword>
  <keyword>Acetabular cup replacement</keyword>
  <keyword>Acetabulum arthroplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Joint Diseases</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment at orthopaedic clinics began Nov 2006 and ended Dec 2009</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>A ASR™-XL</title>
          <description>ASR™-XL Modular Acetabular Cup System stem</description>
        </group>
        <group group_id="P2">
          <title>B Pinnacle™</title>
          <description>Pinnacle™ acetabular shell, with a 28mm or 36mm ULTAMET® metal liner, and a 28mm or 36mm Articul/eze M head.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="130"/>
                <participants group_id="P2" count="135"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="112"/>
                <participants group_id="P2" count="119"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
                <participants group_id="P2" count="16"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>ASR XL</title>
          <description>ASR™-XL Acetabular Cup System</description>
        </group>
        <group group_id="B2">
          <title>Pinnacle MoM</title>
          <description>Pinnacle metal on metal acetabular cup system</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="130"/>
            <count group_id="B2" value="135"/>
            <count group_id="B3" value="265"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59.7" spread="8.6"/>
                    <measurement group_id="B2" value="59.4" spread="9.4"/>
                    <measurement group_id="B3" value="59.6" spread="9.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                    <measurement group_id="B2" value="51"/>
                    <measurement group_id="B3" value="111"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="70"/>
                    <measurement group_id="B2" value="84"/>
                    <measurement group_id="B3" value="154"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="130"/>
                    <measurement group_id="B2" value="135"/>
                    <measurement group_id="B3" value="265"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI</title>
          <description>Body mass index</description>
          <units>lb/in^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.7" spread="7.0"/>
                    <measurement group_id="B2" value="30.1" spread="6.0"/>
                    <measurement group_id="B3" value="29.9" spread="6.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Composite Success Based Upon Harris Hip Score, Radiographic and Survivorship Outcomes</title>
        <description>&quot;Composite success: 1) Revision free (life of study) 2) No evidence of radiographic failure (life of study) 3) Harris Hip score =&gt; 80 at 24 months&quot;</description>
        <time_frame>24-month interval.</time_frame>
        <population>Out of the 265 enrolled subjects, 51 subjects were removed from the analysis for the following reasons: 2 deaths (1 inv, 1 control); 4 protocol violations (0 inv, 4 control); 6 consent withdrawn (2 inv, 4 control); 39 lost to follow-up (17 inv, 22 control).</population>
        <group_list>
          <group group_id="O1">
            <title>ASR XL Acetabular Cup System</title>
          </group>
          <group group_id="O2">
            <title>Pinnacle Acetabular Cup System</title>
          </group>
        </group_list>
        <measure>
          <title>Composite Success Based Upon Harris Hip Score, Radiographic and Survivorship Outcomes</title>
          <description>&quot;Composite success: 1) Revision free (life of study) 2) No evidence of radiographic failure (life of study) 3) Harris Hip score =&gt; 80 at 24 months&quot;</description>
          <population>Out of the 265 enrolled subjects, 51 subjects were removed from the analysis for the following reasons: 2 deaths (1 inv, 1 control); 4 protocol violations (0 inv, 4 control); 6 consent withdrawn (2 inv, 4 control); 39 lost to follow-up (17 inv, 22 control).</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="110"/>
                <count group_id="O2" value="104"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82"/>
                    <measurement group_id="O2" value="92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>A non-inferiority test of the proportion successful for each treatment group will be the primary test of efficacy in this investigation. The null hypothesis is Ho: Xc-Xt ≥ 0.08 and the alternative hypothesis is HA:Xc-Xt &lt; 0.08 Sample size of 126 per group was needed assuming 93% success rates, this was increased to 150 per group to account for attrition.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>non inferiority of proportion successful with 8% non inferiority margin at 24 months</non_inferiority_desc>
            <p_value>0.872</p_value>
            <method>Chi-squared</method>
            <param_type>percentage difference</param_type>
            <param_value>.139</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>1-Sided</ci_n_sides>
            <ci_upper_limit>.225</ci_upper_limit>
            <estimate_desc>The upper confidence limit was a priori determined to be a secondary endpoint</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>T-Test of Harris Hip Total Score Means at 24 Months</title>
        <description>T-Test of Harris Hip total score means at 24 months</description>
        <time_frame>24 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ASR XL Acetabular Cup System</title>
          </group>
          <group group_id="O2">
            <title>Pinnacle Acetabular Cup System</title>
          </group>
        </group_list>
        <measure>
          <title>T-Test of Harris Hip Total Score Means at 24 Months</title>
          <description>T-Test of Harris Hip total score means at 24 months</description>
          <units>Units on a scale of 0-100,100 is best.</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="110"/>
                <count group_id="O2" value="105"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.8" spread="9.4"/>
                    <measurement group_id="O2" value="96.4" spread="6.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.167</p_value>
            <method>t-test, 2 sided</method>
            <method_desc>Satterthwaite</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Harris Hip Pain Sub Score at 24 Months</title>
        <description>Mean Harris Hip Pain sub score</description>
        <time_frame>24 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ASR XL Acetabular Cup System</title>
          </group>
          <group group_id="O2">
            <title>Pinnacle Acetabular Cup System</title>
          </group>
        </group_list>
        <measure>
          <title>Harris Hip Pain Sub Score at 24 Months</title>
          <description>Mean Harris Hip Pain sub score</description>
          <units>units on scale of 0-44. 44 is best</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="110"/>
                <count group_id="O2" value="106"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.5" spread="6.0"/>
                    <measurement group_id="O2" value="42.7" spread="3.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Harris Hip Function Score at 24 Months</title>
        <description>Mean Harris Hip Function sub score at 24 months</description>
        <time_frame>24 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ASR XL Acetabular Cup System</title>
          </group>
          <group group_id="O2">
            <title>Pinnacle Acetabular Cup System</title>
          </group>
        </group_list>
        <measure>
          <title>Harris Hip Function Score at 24 Months</title>
          <description>Mean Harris Hip Function sub score at 24 months</description>
          <units>units on a scale 0-47. 47 is best</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="110"/>
                <count group_id="O2" value="105"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.4" spread="3.6"/>
                    <measurement group_id="O2" value="31.6" spread="3.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Analysis of Metal Ion Release - Serum Cobalt</title>
        <description>Serum Cobalt</description>
        <time_frame>Pre-operative</time_frame>
        <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
        <group_list>
          <group group_id="O1">
            <title>ASR XL Acetabular Cup System</title>
          </group>
          <group group_id="O2">
            <title>Pinnacle Acetabular Cup System</title>
          </group>
        </group_list>
        <measure>
          <title>Analysis of Metal Ion Release - Serum Cobalt</title>
          <description>Serum Cobalt</description>
          <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
          <units>ug/L</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.10" lower_limit="0.07" upper_limit="0.18"/>
                    <measurement group_id="O2" value="0.10" lower_limit="0.06" upper_limit="0.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.457</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Analysis of Metal Ion Release - Serum Chromium</title>
        <description>Serum Chromium</description>
        <time_frame>pre-operative</time_frame>
        <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
        <group_list>
          <group group_id="O1">
            <title>ASR XL Acetabular Cup System</title>
          </group>
          <group group_id="O2">
            <title>Pinnacle Acetabular Cup System</title>
          </group>
        </group_list>
        <measure>
          <title>Analysis of Metal Ion Release - Serum Chromium</title>
          <description>Serum Chromium</description>
          <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
          <units>ug/L</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.12" lower_limit="0.07" upper_limit="1.30"/>
                    <measurement group_id="O2" value="0.12" lower_limit="0.07" upper_limit="2.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.762</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Analysis of Metal Ion Release - Erythrocyte Cobalt</title>
        <description>Erythrocyte cobalt</description>
        <time_frame>pre-operative</time_frame>
        <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
        <group_list>
          <group group_id="O1">
            <title>ASR XL Acetabular Cup System</title>
          </group>
          <group group_id="O2">
            <title>Pinnacle Acetabular Cup System</title>
          </group>
        </group_list>
        <measure>
          <title>Analysis of Metal Ion Release - Erythrocyte Cobalt</title>
          <description>Erythrocyte cobalt</description>
          <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
          <units>ug/L</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.07" lower_limit="0.05" upper_limit="1.26"/>
                    <measurement group_id="O2" value="0.08" lower_limit="0.04" upper_limit="0.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.869</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Analysis of Metal Ion Release - Erythrocyte Chromium</title>
        <description>Erythrocyte Chromium</description>
        <time_frame>Pre-operative</time_frame>
        <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
        <group_list>
          <group group_id="O1">
            <title>ASR XL Acetabular Cup System</title>
          </group>
          <group group_id="O2">
            <title>Pinnacle Acetabular Cup System</title>
          </group>
        </group_list>
        <measure>
          <title>Analysis of Metal Ion Release - Erythrocyte Chromium</title>
          <description>Erythrocyte Chromium</description>
          <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
          <units>ug/L</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.55" lower_limit="0.20" upper_limit="59.45"/>
                    <measurement group_id="O2" value="0.62" lower_limit="0.15" upper_limit="2.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.799</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Analysis of Metal Ion Release - Serum Cobalt</title>
        <description>Serum Cobalt</description>
        <time_frame>4 months post-operative</time_frame>
        <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
        <group_list>
          <group group_id="O1">
            <title>ASR XL Acetabular Cup System</title>
          </group>
          <group group_id="O2">
            <title>Pinnacle Acetabular Cup System</title>
          </group>
        </group_list>
        <measure>
          <title>Analysis of Metal Ion Release - Serum Cobalt</title>
          <description>Serum Cobalt</description>
          <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
          <units>ug/L</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.39" lower_limit="0.06" upper_limit="10.52"/>
                    <measurement group_id="O2" value="0.51" lower_limit="0.22" upper_limit="2.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>HO: Pinnacle=ASR-XL. The alternative hypothesis is HA: Pinnacle≠ASR-XL. Serum cobalt ions were expected to be lower in the ASR-XL group</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Analysis of Metal Ion Release - Serum Chromium</title>
        <description>Serum Chromium</description>
        <time_frame>4 months post operative</time_frame>
        <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
        <group_list>
          <group group_id="O1">
            <title>ASR XL Acetabular Cup System</title>
          </group>
          <group group_id="O2">
            <title>Pinnacle Acetabular Cup System</title>
          </group>
        </group_list>
        <measure>
          <title>Analysis of Metal Ion Release - Serum Chromium</title>
          <description>Serum Chromium</description>
          <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
          <units>ug/L</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.38" lower_limit="0.17" upper_limit="7.67"/>
                    <measurement group_id="O2" value="0.72" lower_limit="0.25" upper_limit="2.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>HO: Pinnacle=ASR-XL. The alternative hypothesis is HA: Pinnacle≠ASR-XL. Serum chromium ions were expected to be lower in the ASR-XL group</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.032</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Analysis of Metal Ion Release - Erythrocyte Cobalt</title>
        <description>Erythrocyte Cobalt</description>
        <time_frame>4 months post-operative</time_frame>
        <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
        <group_list>
          <group group_id="O1">
            <title>ASR XL Acetabular Cup System</title>
          </group>
          <group group_id="O2">
            <title>Pinnacle Acetabular Cup System</title>
          </group>
        </group_list>
        <measure>
          <title>Analysis of Metal Ion Release - Erythrocyte Cobalt</title>
          <description>Erythrocyte Cobalt</description>
          <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
          <units>ug/L</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.85" lower_limit="0.06" upper_limit="8.41"/>
                    <measurement group_id="O2" value="0.26" lower_limit="0.17" upper_limit="0.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>HO: Pinnacle=ASR-XL. The alternative hypothesis is HA: Pinnacle≠ASR-XL. Erythrocyte cobalt ions were expected to be lower in the ASR-XL group</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Analysis of Metal Ion Release - Erythrocyte Chromium</title>
        <description>Erythrocyte Chromium</description>
        <time_frame>4 months post-operative</time_frame>
        <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
        <group_list>
          <group group_id="O1">
            <title>ASR XL Acetabular Cup System</title>
          </group>
          <group group_id="O2">
            <title>Pinnacle Acetabular Cup System</title>
          </group>
        </group_list>
        <measure>
          <title>Analysis of Metal Ion Release - Erythrocyte Chromium</title>
          <description>Erythrocyte Chromium</description>
          <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
          <units>ug/L</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.45" lower_limit="0.24" upper_limit="11.53"/>
                    <measurement group_id="O2" value="0.50" lower_limit="0.15" upper_limit="2.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>HO: Pinnacle=ASR-XL. The alternative hypothesis is HA: Pinnacle≠ASR-XL. Erythrocyte chromium ions were expected to be lower in the ASR-XL group</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.882</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Analysis of Metal Ion Release - Serum Cobalt</title>
        <description>Serum Cobalt</description>
        <time_frame>12 months post-operative</time_frame>
        <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
        <group_list>
          <group group_id="O1">
            <title>ASR XL</title>
            <description>ASR™-XL Acetabular Cup System</description>
          </group>
          <group group_id="O2">
            <title>Pinnacle MoM</title>
            <description>Pinnacle metal on metal acetabular cup system</description>
          </group>
        </group_list>
        <measure>
          <title>Analysis of Metal Ion Release - Serum Cobalt</title>
          <description>Serum Cobalt</description>
          <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
          <units>ug/L</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.55" lower_limit="0.35" upper_limit="25.38"/>
                    <measurement group_id="O2" value="0.98" lower_limit="0.17" upper_limit="5.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>HO: Pinnacle=ASR-XL. The alternative hypothesis is HA: Pinnacle≠ASR-XL. Serum cobalt ions were expected to be lower in the ASR-XL group</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.005</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Analysis of Metal Ion Release - Serum Chromium</title>
        <description>Serum Chromium</description>
        <time_frame>12 Months</time_frame>
        <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
        <group_list>
          <group group_id="O1">
            <title>ASR XL Acetabular Cup System</title>
          </group>
          <group group_id="O2">
            <title>Pinnacle Acetabular Cup System</title>
          </group>
        </group_list>
        <measure>
          <title>Analysis of Metal Ion Release - Serum Chromium</title>
          <description>Serum Chromium</description>
          <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
          <units>ug/L</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.37" lower_limit="0.29" upper_limit="28.62"/>
                    <measurement group_id="O2" value="1.19" lower_limit="0.39" upper_limit="7.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>HO: Pinnacle=ASR-XL. The alternative hypothesis is HA: Pinnacle≠ASR-XL. Serum chromium ions were expected to be lower in the ASR-XL group</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.237</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Analysis of Metal Ion Release - Erythrocyte Cobalt</title>
        <description>Erythrocyte Cobalt</description>
        <time_frame>12 Months</time_frame>
        <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
        <group_list>
          <group group_id="O1">
            <title>ASR XL Acetabular Cup System</title>
          </group>
          <group group_id="O2">
            <title>Pinnacle Acetabular Cup System</title>
          </group>
        </group_list>
        <measure>
          <title>Analysis of Metal Ion Release - Erythrocyte Cobalt</title>
          <description>Erythrocyte Cobalt</description>
          <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
          <units>ug/L</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.91" lower_limit="0.26" upper_limit="29.60"/>
                    <measurement group_id="O2" value="0.41" lower_limit="0.14" upper_limit="3.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>HO: Pinnacle=ASR-XL. The alternative hypothesis is HA: Pinnacle≠ASR-XL. Erythrocyte cobalt ions were expected to be lower in the ASR-XL group</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Analysis of Metal Ion Release - Erythrocyte Chromium</title>
        <description>Erythrocyte Chromium</description>
        <time_frame>12 months</time_frame>
        <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
        <group_list>
          <group group_id="O1">
            <title>ASR XL Acetabular Cup System</title>
          </group>
          <group group_id="O2">
            <title>Pinnacle Acetabular Cup System</title>
          </group>
        </group_list>
        <measure>
          <title>Analysis of Metal Ion Release - Erythrocyte Chromium</title>
          <description>Erythrocyte Chromium</description>
          <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
          <units>ug/L</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.12" lower_limit="0.35" upper_limit="22.83"/>
                    <measurement group_id="O2" value="0.58" lower_limit="0.20" upper_limit="4.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>HO: Pinnacle=ASR-XL. The alternative hypothesis is HA: Pinnacle≠ASR-XL. Erythrocyte chromium ions were expected to be lower in the ASR-XL group</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.121</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Analysis of Metal Ion Release - Serum Cobalt</title>
        <description>Serum Cobalt</description>
        <time_frame>24 months</time_frame>
        <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
        <group_list>
          <group group_id="O1">
            <title>ASR XL Acetabular Cup System</title>
          </group>
          <group group_id="O2">
            <title>Pinnacle Acetabular Cup System</title>
          </group>
        </group_list>
        <measure>
          <title>Analysis of Metal Ion Release - Serum Cobalt</title>
          <description>Serum Cobalt</description>
          <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
          <units>ug/L</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.26" lower_limit="0.36" upper_limit="29.14"/>
                    <measurement group_id="O2" value="1.15" lower_limit="0.22" upper_limit="9.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>HO: Pinnacle=ASR-XL. The alternative hypothesis is HA: Pinnacle≠ASR-XL. Serum Cobalt ions were expected to be lower in the ASR-XL group</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.012</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Analysis of Metal Ion Release - Serum Chromium</title>
        <description>Serum Chromium</description>
        <time_frame>24 months</time_frame>
        <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
        <group_list>
          <group group_id="O1">
            <title>ASR XL Acetabular Cup System</title>
          </group>
          <group group_id="O2">
            <title>Pinnacle Acetabular Cup System</title>
          </group>
        </group_list>
        <measure>
          <title>Analysis of Metal Ion Release - Serum Chromium</title>
          <description>Serum Chromium</description>
          <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
          <units>ug/L</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.30" lower_limit="0.32" upper_limit="26.67"/>
                    <measurement group_id="O2" value="1.48" lower_limit="0.62" upper_limit="7.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>HO: Pinnacle=ASR-XL. The alternative hypothesis is HA: Pinnacle≠ASR-XL. Serum chromium ions were expected to be lower in the ASR-XL group</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.103</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Analysis of Metal Ion Release - Erythrocyte Cobalt</title>
        <description>Erythrocyte Cobalt</description>
        <time_frame>24 months</time_frame>
        <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
        <group_list>
          <group group_id="O1">
            <title>ASR XL Acetabular Cup System</title>
          </group>
          <group group_id="O2">
            <title>Pinnacle Acetabular Cup System</title>
          </group>
        </group_list>
        <measure>
          <title>Analysis of Metal Ion Release - Erythrocyte Cobalt</title>
          <description>Erythrocyte Cobalt</description>
          <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
          <units>ug/L</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.61" lower_limit="0.25" upper_limit="37.55"/>
                    <measurement group_id="O2" value="0.63" lower_limit="0.20" upper_limit="2.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>HO: Pinnacle=ASR-XL. The alternative hypothesis is HA: Pinnacle≠ASR-XL. Erythrocyte cobalt ions were expected to be lower in the ASR-XL group</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Analysis of Metal Ion Release - Erythrocyte Chromium</title>
        <description>Erythrocyte Chromium</description>
        <time_frame>24 months</time_frame>
        <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
        <group_list>
          <group group_id="O1">
            <title>ASR XL Acetabular Cup System</title>
          </group>
          <group group_id="O2">
            <title>Pinnacle Acetabular Cup System</title>
          </group>
        </group_list>
        <measure>
          <title>Analysis of Metal Ion Release - Erythrocyte Chromium</title>
          <description>Erythrocyte Chromium</description>
          <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
          <units>ug/L</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.29" lower_limit="0.24" upper_limit="7.90"/>
                    <measurement group_id="O2" value="1.00" lower_limit="0.20" upper_limit="3.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>HO: Pinnacle=ASR-XL. The alternative hypothesis is HA: Pinnacle≠ASR-XL. Erythrocyte chromium ions were expected to be lower in the ASR-XL group</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.300</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Analysis of Metal Ion Release - Serum Cobalt</title>
        <description>Serum Cobalt</description>
        <time_frame>36 months</time_frame>
        <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
        <group_list>
          <group group_id="O1">
            <title>ASR XL Acetabular Cup System</title>
          </group>
          <group group_id="O2">
            <title>Pinnacle Acetabular Cup System</title>
          </group>
        </group_list>
        <measure>
          <title>Analysis of Metal Ion Release - Serum Cobalt</title>
          <description>Serum Cobalt</description>
          <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
          <units>ug/L</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.17" lower_limit="0.77" upper_limit="33.85"/>
                    <measurement group_id="O2" value="2.19" lower_limit="0.36" upper_limit="12.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>HO: Pinnacle=ASR-XL. The alternative hypothesis is HA: Pinnacle≠ASR-XL. Serum cobalt ions were expected to be lower in the ASR-XL group</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.079</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Analysis of Metal Ion Release - Serum Chromium</title>
        <description>Serum Chromium</description>
        <time_frame>36 months</time_frame>
        <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
        <group_list>
          <group group_id="O1">
            <title>ASR XL Acetabular Cup System</title>
          </group>
          <group group_id="O2">
            <title>Pinnacle Acetabular Cup System</title>
          </group>
        </group_list>
        <measure>
          <title>Analysis of Metal Ion Release - Serum Chromium</title>
          <description>Serum Chromium</description>
          <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
          <units>ug/L</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.80" lower_limit="0.59" upper_limit="26.77"/>
                    <measurement group_id="O2" value="1.57" lower_limit="0.27" upper_limit="8.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>HO: Pinnacle=ASR-XL. The alternative hypothesis is HA: Pinnacle≠ASR-XL. Serum chromium ions were expected to be lower in the ASR-XL group</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.766</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Analysis of Metal Ion Release - Erythrocyte Cobalt</title>
        <description>Erythrocyte cobalt</description>
        <time_frame>36 months</time_frame>
        <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
        <group_list>
          <group group_id="O1">
            <title>ASR XL Acetabular Cup System</title>
          </group>
          <group group_id="O2">
            <title>Pinnacle Acetabular Cup System</title>
          </group>
        </group_list>
        <measure>
          <title>Analysis of Metal Ion Release - Erythrocyte Cobalt</title>
          <description>Erythrocyte cobalt</description>
          <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
          <units>ug/L</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.06" lower_limit="0.47" upper_limit="54.65"/>
                    <measurement group_id="O2" value="1.20" lower_limit="0.26" upper_limit="4.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>HO: Pinnacle=ASR-XL. The alternative hypothesis is HA: Pinnacle≠ASR-XL. Erythrocyte cobalt ions were expected to be lower in the ASR-XL group</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.018</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Analysis of Metal Ion Release - Erythrocyte Chromium</title>
        <description>Erythrocyte chromium</description>
        <time_frame>36 months</time_frame>
        <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
        <group_list>
          <group group_id="O1">
            <title>ASR XL Acetabular Cup System</title>
          </group>
          <group group_id="O2">
            <title>Pinnacle Acetabular Cup System</title>
          </group>
        </group_list>
        <measure>
          <title>Analysis of Metal Ion Release - Erythrocyte Chromium</title>
          <description>Erythrocyte chromium</description>
          <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
          <units>ug/L</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.76" lower_limit="0.18" upper_limit="7.82"/>
                    <measurement group_id="O2" value="0.73" lower_limit="0.22" upper_limit="3.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>HO: Pinnacle=ASR-XL. The alternative hypothesis is HA: Pinnacle≠ASR-XL. Erythrocyte chromium ions were expected to be lower in the ASR-XL group</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.689</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Analysis of Metal Ion Release - Serum Cobalt</title>
        <description>Serum Cobalt</description>
        <time_frame>48 months</time_frame>
        <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
        <group_list>
          <group group_id="O1">
            <title>ASR XL Acetabular Cup System</title>
          </group>
          <group group_id="O2">
            <title>Pinnacle Acetabular Cup System</title>
          </group>
        </group_list>
        <measure>
          <title>Analysis of Metal Ion Release - Serum Cobalt</title>
          <description>Serum Cobalt</description>
          <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
          <units>ug/L</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.16" lower_limit="0.66" upper_limit="33.78"/>
                    <measurement group_id="O2" value="1.83" lower_limit="0.46" upper_limit="7.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>HO: Pinnacle=ASR-XL. The alternative hypothesis is HA: Pinnacle≠ASR-XL. Serum cobalt ions were expected to be lower in the ASR-XL group</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.048</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Analysis of Metal Ion Release - Serum Chromium</title>
        <description>Serum Chromium</description>
        <time_frame>48 months</time_frame>
        <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
        <group_list>
          <group group_id="O1">
            <title>ASR XL Acetabular Cup System</title>
          </group>
          <group group_id="O2">
            <title>Pinnacle Acetabular Cup System</title>
          </group>
        </group_list>
        <measure>
          <title>Analysis of Metal Ion Release - Serum Chromium</title>
          <description>Serum Chromium</description>
          <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
          <units>ug/L</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.04" lower_limit="0.68" upper_limit="25.25"/>
                    <measurement group_id="O2" value="1.66" lower_limit="0.36" upper_limit="6.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>HO: Pinnacle=ASR-XL. The alternative hypothesis is HA: Pinnacle≠ASR-XL. Serum chromium ions were expected to be lower in the ASR-XL group</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.782</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Analysis of Metal Ion Release - Erythrocyte Cobalt</title>
        <description>Erythrocyte Cobalt</description>
        <time_frame>48 months</time_frame>
        <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
        <group_list>
          <group group_id="O1">
            <title>ASR XL Acetabular Cup System</title>
          </group>
          <group group_id="O2">
            <title>Pinnacle Acetabular Cup System</title>
          </group>
        </group_list>
        <measure>
          <title>Analysis of Metal Ion Release - Erythrocyte Cobalt</title>
          <description>Erythrocyte Cobalt</description>
          <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
          <units>ug/L</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.90" lower_limit="0.58" upper_limit="40.89"/>
                    <measurement group_id="O2" value="1.18" lower_limit="0.20" upper_limit="3.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>HO: Pinnacle=ASR-XL. The alternative hypothesis is HA: Pinnacle≠ASR-XL. Erythrocyte cobalt ions were expected to be lower in the ASR-XL group</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.061</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Analysis of Metal Ion Release - Erythrocyte Chromium</title>
        <description>Erythrocyte chromium</description>
        <time_frame>48 months</time_frame>
        <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
        <group_list>
          <group group_id="O1">
            <title>ASR XL Acetabular Cup System</title>
          </group>
          <group group_id="O2">
            <title>Pinnacle Acetabular Cup System</title>
          </group>
        </group_list>
        <measure>
          <title>Analysis of Metal Ion Release - Erythrocyte Chromium</title>
          <description>Erythrocyte chromium</description>
          <population>Metal ion sub-study was limited to two sites. All participants with available data are presented below.</population>
          <units>ug/L</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.62" lower_limit="0.21" upper_limit="4.21"/>
                    <measurement group_id="O2" value="0.62" lower_limit="0.33" upper_limit="1.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>HO: Pinnacle=ASR-XL. The alternative hypothesis is HA: Pinnacle≠ASR-XL. Erythrocyte chromium ions were expected to be lower in the ASR-XL group</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.957</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>AE data were collected at 1 month, 4 months, 12 months, 24 months, and annually until study closure. Longest post operative interval with AE data was 60 months.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>ASR XL Acetabular Cup System</title>
        </group>
        <group group_id="E2">
          <title>Pinnacle Acetabular Cup System</title>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA 16.0</default_vocab>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="72" subjects_at_risk="130"/>
                <counts group_id="E2" subjects_affected="59" subjects_at_risk="135"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Sinus tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Hip dysplasia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Device component issue</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Device dislocation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Medical device complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Medical device site reaction</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="130"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Adverse drug reaction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Multiple sclerosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="5" subjects_affected="3" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Laryngitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Oral candidacies</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Tooth abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Fracture</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Gun shot wound</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Iliotibial band syndrome</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="130"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Ligament sprain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Meniscus injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Muscle strain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Postoperative heterotopic calcification</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Radius fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Wound complication</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="130"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Epicondylitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood heavy metal increased</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Hematocrit decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>White blood cell increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Hypokalemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="20" subjects_affected="9" subjects_at_risk="130"/>
                <counts group_id="E2" events="15" subjects_affected="11" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Arthralgia joint swelling</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Back disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="130"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Bone loss</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" events="19" subjects_affected="12" subjects_at_risk="130"/>
                <counts group_id="E2" events="10" subjects_affected="8" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Groin pain</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="130"/>
                <counts group_id="E2" events="5" subjects_affected="3" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Joint crepitation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Joint lock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Joint swelling</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Muscle disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Musculoskeletal discomfort</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Myositis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" events="11" subjects_affected="8" subjects_at_risk="130"/>
                <counts group_id="E2" events="9" subjects_affected="7" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Pathological fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Plantar Fascitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Rheumatoid arthritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Rotataor cuff syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Spinal column stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Spondylolisthesis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Tendonitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="130"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="135"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Lung cancer metastatic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Neoplasm malignant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Carpal tunnel syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Paresthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Piriformis syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal failure acute</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Pulmonary fibrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Pulmonary mass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Angioplasty</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Hip arthroplasty</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="130"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Knee arthroplasty</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Knee operation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Post procedural drainage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Shoulder operation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="135"/>
              </event>
              <event>
                <sub_title>Varicose vein</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="135"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>At study inception, information on whether or not an adverse event was deemed to be serious was not collected. Because of this caveat, the Sponsor has reported all adverse events that occurred.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dave Whalen Clinical Portfolio Leader</name_or_title>
      <organization>DePuy Orthopaedics</organization>
      <phone>574-372-7028</phone>
      <email>dwhalen@its.jnj.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

